V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002045 | 210005672 | null | 100.7 | null | 2017-03-02 | 2017-03-07 | Trastuzumab | 02 | null | TRASTUZUMAB | 100063032 |
| 210002046 | 210005673 | 1.58 | 62.25 | Adjuvant (A) | null | 2018-12-21 | Trastuzumab | 02 | N | TRASTUZUMAB | 101106294 |
| 210002047 | 210005674 | 1.58 | 115 | Adjuvant (A) | 2019-03-11 | 2019-03-28 | Docetaxel | 02 | N | DOCETAXEL | 100509970 |
| 210002048 | 210005675 | null | 77.3 | null | 2018-06-23 | 2018-07-07 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101037279 |
| 210002051 | 210005677 | 1.58 | 104.6 | Adjuvant (A) | 2017-02-08 | 2017-02-22 | Trastuzumab | N | N | TRASTUZUMAB | 101264582 |
| 210002052 | 210005678 | null | 78.3 | null | null | 2020-02-13 | Trastuzumab | 02 | null | TRASTUZUMAB | 100843902 |
| 210002053 | 210005679 | 1.54 | 65 | Adjuvant (A) | 2018-01-16 | 2018-02-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100690129 |
| 210002054 | 210005680 | null | 68.4 | null | 2019-03-24 | 2019-04-06 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100572563 |
| 210002056 | 210005681 | 1.56 | 86.8 | Neo-adjuvant (N) | 2017-04-17 | 2017-04-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101228408 |
| 210002057 | 210005682 | 1.72 | 114.8 | Adjuvant (A) | 2017-03-27 | 2017-08-19 | Docetaxel | 02 | null | DOCETAXEL | 101085260 |
| 210002061 | 210005685 | 1.59 | 62 | Adjuvant (A) | 2018-04-09 | 2018-04-16 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100386241 |
| 210002063 | 210005686 | null | 69 | null | null | 2018-11-10 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101056967 |
| 210002064 | 210005687 | 1.63 | 82.9 | Adjuvant (A) | null | 2018-10-10 | PACLITAXEL | null | N | PACLITAXEL | 100742580 |
| 210002065 | 210005688 | 1.54 | 70.1 | Adjuvant (A) | 2016-11-14 | 2016-11-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100564124 |
| 210002066 | 210005689 | 1.69 | 70.1 | Adjuvant (A) | null | 2017-10-22 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100376474 |
| 210002068 | 210005690 | 1.48 | 86.9 | Adjuvant (A) | null | 2019-12-07 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100738514 |
| 210002070 | 210005691 | null | 58.5 | null | 2018-01-16 | 2018-01-31 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100870029 |
| 210002072 | 210005693 | 1.6 | 94.1 | Adjuvant (A) | 2018-12-29 | 2019-01-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100533998 |
| 210002073 | 210005694 | 1.69 | 77.6 | Adjuvant (A) | null | 2018-06-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100713396 |
| 210002074 | 210005695 | 1.5 | null | Adjuvant (A) | 2015-12-24 | 2016-01-08 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100111950 |
| 210002075 | 210005696 | 1.67 | 78 | Adjuvant (A) | 2017-08-22 | 2017-09-02 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101379181 |
| 210002076 | 210005697 | null | 95.9 | null | 2018-12-27 | 2019-05-12 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101581729 |
| 210002077 | 210005698 | 1.6 | 86.4 | Adjuvant (A) | null | 2016-08-27 | PACLITAXEL | 02 | N | PACLITAXEL | 100056205 |
| 210002080 | 210005699 | 1.74 | 69.1 | Adjuvant (A) | 2017-06-16 | 2017-07-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100458032 |
| 210002085 | 210005701 | 1.6 | 93 | Adjuvant (A) | 2021-01-28 | 2021-02-03 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101460439 |
| 210002087 | 210005703 | 1.64 | 92.4 | null | 2019-08-31 | 2019-09-28 | Trastuzumab | 02 | N | TRASTUZUMAB | 101510750 |
| 210002088 | 210005704 | 1.61 | 111.3 | Adjuvant (A) | 2018-06-15 | 2018-06-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101794845 |
| 210002089 | 210005705 | 1.62 | 82.6 | null | 2016-06-10 | 2016-06-24 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101650942 |
| 210002090 | 210005706 | 1.61 | 90.7 | Adjuvant (A) | null | 2018-08-03 | TRASTUZUMAB | 01 | N | TRASTUZUMAB | 101069257 |
| 210002091 | 210005707 | 1.63 | 58.1 | Adjuvant (A) | 2019-09-23 | 2019-09-29 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101005329 |
| 210002092 | 210005708 | null | 53.4 | null | 2017-02-14 | 2017-02-22 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101669089 |
| 210002093 | 210005709 | null | 84.7 | null | 2017-08-05 | 2018-02-27 | PACLITAXEL | null | null | PACLITAXEL | 100192656 |
| 210002094 | 210005710 | 1.51 | 81.1 | Neo-adjuvant (N) | 2017-03-23 | 2017-04-11 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100575007 |
| 210002095 | 210005711 | 1.61 | 69.7 | Palliative (P) | null | 2018-06-01 | Docetaxel | null | N | DOCETAXEL | 101465692 |
| 210002096 | 210005712 | 1.5 | 92.5 | Adjuvant (A) | 2018-02-23 | 2018-03-10 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100667282 |
| 210002097 | 210005713 | 1.73 | 104.4 | Adjuvant (A) | 2019-11-13 | 2020-04-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100135959 |
| 210002103 | 210005716 | null | 81.4 | null | 2018-10-07 | 2018-10-28 | Docetaxel | 02 | null | DOCETAXEL | 101671682 |
| 210002107 | 210005720 | null | 63 | null | 2017-02-17 | 2017-03-07 | Docetaxel | 02 | null | DOCETAXEL | 101536240 |
| 210002110 | 210005723 | 1.59 | 63.1 | Neo-adjuvant (N) | 2018-09-23 | 2018-12-07 | Docetaxel | 02 | N | DOCETAXEL | 101266857 |
| 210002111 | 210005724 | 1.56 | 53.8 | Adjuvant (A) | 2019-10-11 | 2019-10-24 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100630699 |
| 210002112 | 210005725 | 1.67 | 72.4 | Adjuvant (A) | 2016-08-22 | 2016-08-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100717205 |
| 210002113 | 210005726 | null | null | null | 2016-09-06 | 2016-09-15 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101788633 |
| 210002114 | 210005727 | null | 85.2 | null | 2016-06-19 | 2016-07-08 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100753770 |
| 210002115 | 210005728 | 1.69 | 51.9 | null | 2016-07-10 | 2016-07-10 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100876365 |
| 210002116 | 210005729 | 1.64 | 74 | Adjuvant (A) | 2016-08-25 | 2016-11-21 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101094922 |
| 210002117 | 210005730 | 1.71 | null | Adjuvant (A) | 2017-08-08 | 2018-02-10 | Trastuzumab 21 day maintenance | null | N | TRASTUZUMAB | 101064074 |
| 210002118 | 210005731 | 1.65 | 78.1 | Adjuvant (A) | 2018-06-19 | 2018-09-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101785768 |
| 210002121 | 210005733 | 1.52 | 73.2 | null | null | 2018-04-09 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101636290 |
| 210002122 | 210005734 | 1.47 | 110.7 | Adjuvant (A) | 2018-06-16 | 2018-07-08 | Docetaxel | 02 | N | DOCETAXEL | 101273372 |
| 210002123 | 210005735 | 1.6 | 77.1 | Adjuvant (A) | 2017-01-13 | 2017-02-09 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101535862 |